U.S. puts Canada on watch list over drug-patent policy

05/7/2013 | Financial Post (Canada)

The Office of the U.S. Trade Representative expressed concern over Canada's treatment of pharmaceutical patents in a newly issued report on intellectual-property issues. The trade office placed Canada on its watch list for issues relating to the lack of appeal rights for innovative companies and heightened utility requirements that may violate trade agreements.

View Full Article in:

Financial Post (Canada)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA